Microtest Diagnostics was spun out of London’s Imperial College in 2002 with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&D investment, Microtest Diagnostics recently received the CE-mark for its instrument.
We will never sell your
email address to any 3rd party or send you nasty spam.
HAVE WE MADE ALLERGY TESTING TOO EASY?
Only a few drops of blood is all we need We need 100μL of serum/plasma. You need the rest, so keep it!
allergy lab for your doctor
Why send the blood to a lab, when the lab can come to the blood? With our instrument users can run up to 5 patients' samples in parallel! Wondering about the size? It's only 78x37x42 cm and it weights 15 kg (excl. laptop computer).
Why bother with complicated lab protocols? With our system the only thing you need to do is place the blood sample on a disposable chip, insert the self-contained disposable reagent pack, and press the start button... You are now Microtest certified!
Platform sensitivity = ~0.1 kU/L of human IgE, equivalent to ~0.3 ng/mL of IgEs. Platform specificity = 100% against IgM, IgA and IgD. 99.6% against IgG. Does this mean anything to you?
Results in ~4 hrs for both Allergen-Specific IgEs concentrations (kU/L) and Class Score (CS) reactivities. How long did you wait for your last test results?
We don't just test a few allergens. Our proprietary microarray technology allows the simultaneous testing of tens of allergen-specific IgEs for both natural and recombinant allergens, all in one single biochip! Your doctor will agree: A full panel test is needed to really understand what's going on inside you.
Kjell Kristiansen, Group Managing Director
* Allergy Reagent Cartridge & Biochip pictures for illustrative purpose only. Microtest Diagnostics products are not FDA certified.
First independent field study successfully
Microtest has successfully completed its first fully independent field trial in Italy. The study produced c.1700 allergen-antibody determinations, which were obtained from skin prick tests and an alternative IVD system. The data have been analysed and compared against the Microtest platform.
October 2012 - January 2013
NEWS AND UPDATES: